The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome

AIDS Research and Human Retroviruses

Volumn 13, Issue 4, 1997, Pages 305-315

  Timpone, J G ^a   Wright, D J ^a   Li, N ^a   Egorin, M J ^a   Enama, M E ^a   Mayers, J ^a   Galetto, G ^a   Gagnon, S ^a   Vargo, J ^a   Chirgwin, K ^a   Marcel, A ^a   Cohn, D ^a   Dudley, M ^a   Geletko, S ^a   Standiford, H ^a   Cervino, K ^a   Mushatt, D M ^a   Greenspan, D ^a   Powderly, W ^a   Meyers, M ^a   Sampson, J H ^a   McMillan, G ^a   Novak, R ^a   Moreira, L ^a   more..

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DRONABINOL; MEGESTROL ACETATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; BLOOD TOXICITY; BODY WEIGHT; CACHEXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; MYASTHENIA; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 8044242331     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.305     Document Type: Article

References (29)